Scrip code |
| Scrip code | 543497 |
| NSE Symbol | |
| MSEI Symbol | |
| ISIN | INE0KQ001017 |
| Name of company | BHATIA COLOUR CHEM LIMITED |
| Result Type | Main Format |
| Type of company | SME |
| Class of security | Equity |
| Date of start of financial year | 01-04-2022 |
| Date of end of financial year | 31-03-2023 |
| Date of board meeting when results were approved | 20-05-2023 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 12-05-2023 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Quarter | Yearly |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Textile Chemical |
| Start date and time of board meeting | 12-05-2023 14:00 |
| End date and time of board meeting | 20-05-2023 19:45 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results � Other than Bank |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) |
| A | Date of start of reporting period | 01-10-2022 | 01-04-2022 |
| B | Date of end of reporting period | 31-03-2023 | 31-03-2023 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. |
| 3 | Profit before exceptional and extraordinary items and tax | 234.874 | 377.319 |
| 4 | Exceptional items | 0.008 | 0.008 |
| 5 | Profit before extraordinary items and tax | 234.882 | 377.327 |
| 6 | Extraordinary items | -2.6 | -3.328 |
| 7 | Profit before tax | 232.282 | 373.999 |
| Current tax | 63.924 | 100.586 |
| Deferred tax | -0.496 | -0.48 |
| Total tax expenses | 63.428 | 100.106 |
| 9 | Net Profit Loss for the period from continuing operations | 168.854 | 273.893 |
| 10 | Profit (loss) from discontinuing operations before tax | 0 | 0 |
| 11 | Tax expense of discontinuing operations | 0 | 0 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0 | 0 |
| 13 | Profit (loss) for period before minority interest | 168.854 | 273.893 |
| 16 | Net profit (Loss) for the period | 168.854 | 273.893 |
Financial Results � Other than Bank |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) |
| A | Date of start of reporting period | 01-10-2022 | 01-04-2022 |
| B | Date of end of reporting period | 31-03-2023 | 31-03-2023 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. |
| 17 | Details of equity share capital |
| Paid-up equity share capital | 122337500 | 122337500 |
| Face value of equity share capital | 10 | 10 |
| 17 | Details of debt securities |
| Basic earnings (loss) per share from continuing and discontinued operations | 1.38 | 2.239 |
| 20 | Debt equity ratio |
| 21 | Debt service coverage ratio | 0.752 | 0.752 |
| 22 | Interest service coverage ratio | 2.203 | 2.203 |
| | |
Statement of Asset and Liabilities |
| Particulars | Current year ended (dd-mm-yyyy) |
| Date of start of reporting period | 01-04-2022 |
| Date of end of reporting period | 31-03-2023 |
| Whether results are audited or unaudited | Audited |
| Nature of report standalone or consolidated | Standalone |
| Equity and liabilities |
| 1 | Shareholders' funds |
| Share capital | 1223.375 |
| Reserves and surplus | 4692.931 |
| Money received against share warrants | 0 |
| Total shareholders' funds | 5916.306 |
| 2 | Share application money pending allotment | 0 |
| 3 | Deferred government grants | 0 |
| 4 | Minority interest | |
| 5 | Non-current liabilities |
| Long-term borrowings | 1930.653 |
| Deferred tax liabilities (net) | 0 |
| Foreign currency monetary item translation difference liability account | 0 |
| Other long-term liabilities | 0 |
| Long-term provisions | 8.086 |
| Total non-current liabilities | 1938.739 |
| 6 | Current liabilities |
| Short-term borrowings | 45.831 |
| Trade Payables |
| (A) Total outstanding dues of micro enterprises and small enterprises | 375.9 |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 2887.585 |
| Other current liabilities | 22.696 |
| Short-term provisions | 108.496 |
| Total current liabilities | 3440.508 |
| Total equity and liabilities | 11295.553 |
| Assets |
| 1 | Non-current assets |
| (i) | Fixed assets |
| Tangible assets | 59.847 |
| Producing properties | 0 |
| Intangible assets | 0.109 |
| Preproducing properties | 0 |
| Tangible assets capital work-in-progress | 0 |
| Intangible assets under development or work-in-progress | 0 |
| Total fixed assets | 59.956 |
Cash flow statement - indirect |
| Particulars | Year ended (dd-mm-yyyy) |
| A | Date of start of reporting period | 01-04-2022 |
| B | Date of end of reporting period | 31-03-2023 |
| C | Whether results are audited or unaudited | Audited |
| D | Nature of report standalone or consolidated | Standalone |
| 1 | Statement of cash flows |
| Cash flows from used in operating activities |
| Profit before extraordinary items and tax | 377.327 |
| 2 | Adjustments for reconcile profit (loss) |
| Adjustments to profit (loss) |
| Adjustments for finance costs | 297.641 |
| Adjustments for depreciation and amortisation expense | 15.838 |
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 |
| Adjustments for unrealised foreign exchange losses gains | 0 |
| Adjustments for dividend income | 0 |
| Adjustments for share-based payments | 0 |
| Other adjustments for which cash effects are investing or financing cash flow | 0 |
| Other adjustments to reconcile profit (loss) | 0 |
| Other adjustments for non-cash items | -0.008 |
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 |
| Total adjustments to profit (loss) | 313.471 |
| 3 | Adjustments for working capital |
| Adjustments for decrease (increase) in inventories | 825.122 |
| Adjustments for decrease (increase) in trade receivables | -728.161 |
| Adjustments for decrease (increase) in other current assets | 64.026 |
| Adjustments for increase (decrease) in trade payables | 557.608 |
| Adjustments for increase (decrease) in other current liabilities | 9.292 |
| Adjustments for provisions | 91.074 |
| Total adjustments for working capital | 818.961 |
| Total adjustments for reconcile profit (loss) | 1132.432 |
| Net cash flows from (used in) operations | 1509.759 |
| Dividends received | 0 |
| Interest paid | 0 |
| Interest received | 0 |
| Income taxes paid (refund) | 100.586 |
| Other inflows (outflows) of cash | 0 |
| Net cash flows from (used in) operating activities before extraordinary items | 1409.173 |
| Proceeds from extraordinary items | 0 |
| Payment for extraordinary items | 3.328 |
| Net cash flows from (used in) operating activities | 1405.845 |
| 4 | Cash flows from used in investing activities |
| Cash flows from losing control of subsidiaries or other businesses | 0 |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 |
| Other cash receipts from sales of equity or debt instruments of other entities | 0 |
| Other cash payments to acquire equity or debt instruments of other entities | 0 |
| Other cash receipts from sales of interests in joint ventures | 0 |
| Other cash payments to acquire interests in joint ventures | 0 |
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 |
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 |
| Proceeds from sales of tangible assets | 2.6 |
| Purchase of tangible assets | 35.622 |
| Proceeds from sales of intangible assets | 0 |
| Purchase of intangible assets | 0 |
| Cash advances and loans made to other parties | 0 |
| Cash receipts from repayment of advances and loans made to other parties | 0 |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 |
| Dividends received | 0 |
| Interest received | 13.18 |
| Income taxes paid (refund) | 0 |
| Other inflows (outflows) of cash | 0 |
| Proceeds from government grants | 0 |
| Net cash flows from (used in) investing activities before extraordinary items | -19.842 |
| Proceeds from extraordinary items | 0 |
| Payment for extraordinary items | 0 |
| Net cash flows from (used in) investing activities | -19.842 |
| 5 | Cash flows from used in financing activities |
| Proceeds from issuing shares | 0 |
| Proceeds from issuing other equity instruments | 0 |
| Proceeds from issuing debentures notes bonds etc | 0 |
| Proceeds from borrowings | 0 |
| Repayments of borrowings | 4445.779 |
| Dividends paid | 0 |
| Interest paid | 310.821 |
| Income taxes paid (refund) | 0 |
| Other inflows (outflows) of cash | 3.2 |
| Net cash flows from (used in) financing activities before extraordinary items | -4753.4 |
| Proceeds from extraordinary items | 0 |
| Payment for extraordinary items | 0 |
| Net cash flows from (used in) financing activities | -4753.4 |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -3367.397 |
| 6 | Effect of exchange rate changes on cash and cash equivalents |
| Effect of exchange rate changes on cash and cash equivalents | 0 |
| Net increase (decrease) in cash and cash equivalents | -3367.397 |
| Cash and cash equivalents cash flow statement at beginning of period | 3396.093 |
| Cash and cash equivalents cash flow statement at end of period | 28.696 |